PTSD Trial, Recruiting NCT05995678 Sponsor: VA Office of Research and Development Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05995678
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You left military service within the last three years
  • You have reported some difficulty with daily functioning or adjusting to civilian life, based on a specific questionnaire about military-to-civilian transition (any area where you said you have "some difficulty" or more)
  • You can read and communicate well enough in English to take part
  • You are willing to participate and have signed the consent and privacy forms

Who may not be able to join:

  • You are currently experiencing active psychosis (a serious mental health condition involving a break from reality, such as hearing or seeing things others do not)
  • You are currently at an immediate, high-level risk of suicide that requires urgent crisis support (note: a lower or non-immediate level of risk may still be allowed — confirm with trial site)
  • You currently have a moderate or severe problem with alcohol or drug use
  • You have been diagnosed with a neurological condition (a condition affecting the brain or nervous system), not including traumatic brain injury (TBI) — if you have TBI, this rule may not apply to you (confirm with trial site)

Additional notes from the trial:

  • A mild substance use issue is allowed
  • People with a mild level of alcohol or drug use difficulty may still be eligible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Catherine B Fortier, PhD, VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Phone: (857) 364-4361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility- recruitment interest; Feasibility- enrollment; Feasibility- qualitative via Narrative Evaluation of Intervention Interview; Feasibility- Treatment Fidelity/adherence; Acceptability- Veteran adherence; Acceptability- Quantitative satisfaction via Client satisfaction questionnaire Change; Reintegration status- Military to Civilian Questionnaire (M2CQ) Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov